In a medical centre in the eastern city of Xuzhou, a few dozen healthy adults have become some of the first to trial a vaccine candidate for the coronavirus.

They are among a small group of people in China, the US and Britain who are pioneering the first human trials of different potential vaccines for COVID-19.

According to the Chinese company behind the Xuzhou vaccine, Sinovac Biotech, they are working around the clock.

“Normally the development of a vaccine will take eight to 10 years,” senior director of overseas business for Sinovac Meng Weining told the ABC.

“For this vaccine, it’s really a pandemic, so we’re trying our best to make it as quick as possible for each step.”

Sinovac — a private company supported by China’s government — previously worked on a SARS vaccine that was abandoned when the deadly virus disappeared in 2003, and in more recent years has developed avian flu and hepatitis vaccines.

It’s now one of five Chinese companies or government research organisations approved to commence human trials as regulators fast-track the process.

“That doesn’t mean we will cut down on certain steps for the development,” Mr Meng said.

“Normally you first do a test and then, according to the result, you do a second test. But, in order to save time, we do all testing in parallel.”

Image Credit:  Sinovac

read the full article

News This Week

Can We Stop a Super Coronavirus?

The new variants of the coronavirus are even more dangerous than those known so far. Researchers and politicians fear a sharp increase in the number of infections, with dramatic consequences like those seen in Britain. [...]

Could COVID-19 have wiped out the Neandertals?

Everybody loves Neandertals, those big-brained brutes we supposedly outcompeted and ultimately replaced using our sharp tongues and quick, delicate minds. But did we really, though? Is it mathematically possible that we could yet be them, [...]